| Treatment of 5 critically ill patients with COVID-19 with convalescent plasma C Shen, Z Wang, F Zhao, Y Yang, J Li, J Yuan, F Wang, D Li, M Yang, ... Jama 323 (16), 1582-1589, 2020 | 2934 | 2020 |
| Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Y Liu, Y Yang, C Zhang, F Huang, F Wang, J Yuan, Z Wang, J Li, J Li, ... Science China Life Sciences 63, 364-374, 2020 | 2552 | 2020 |
| Experimental treatment with favipiravir for COVID-19: an open-label control study Q Cai, M Yang, D Liu, J Chen, D Shu, J Xia, X Liao, Y Gu, Q Cai, Y Yang, ... Engineering 6 (10), 1192-1198, 2020 | 1613 | 2020 |
| A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 Y Wu, F Wang, C Shen, W Peng, D Li, C Zhao, Z Li, S Li, Y Bi, Y Yang, ... Science 368 (6496), 1274-1278, 2020 | 1129 | 2020 |
| Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections Y Yang, M Yang, C Shen, F Wang, J Yuan, J Li, M Zhang, Z Wang, L Xing, ... MedRxiv, 2020.02. 11.20021493, 2020 | 789 | 2020 |
| Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 Y Yang, C Shen, J Li, J Yuan, J Wei, F Huang, F Wang, G Li, Y Li, L Xing, ... Journal of Allergy and Clinical Immunology 146 (1), 119-127. e4, 2020 | 724 | 2020 |
| Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome Y Yang, C Shen, J Li, J Yuan, M Yang, F Wang, G Li, Y Li, L Xing, L Peng, ... MedRxiv, 2020.03. 02.20029975, 2020 | 333 | 2020 |
| Laboratory diagnosis and monitoring the viral shedding of SARS-CoV-2 infection Y Yang, M Yang, J Yuan, F Wang, Z Wang, J Li, M Zhang, L Xing, J Wei, ... The innovation 1 (3), 2020 | 327 | 2020 |
| The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists Y Yang, L Zhang, H Geng, Y Deng, B Huang, Y Guo, Z Zhao, W Tan Protein & cell 4, 951-961, 2013 | 318 | 2013 |
| Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury Y Liu, C Zhang, F Huang, Y Yang, F Wang, J Yuan, Z Zhang, Y Qin, X Li, ... National Science Review 7 (6), 1003-1011, 2020 | 288 | 2020 |
| The architecture of inactivated SARS-CoV-2 with postfusion spikes revealed by cryo-EM and cryo-ET C Liu, L Mendonça, Y Yang, Y Gao, C Shen, J Liu, T Ni, B Ju, C Liu, ... Structure 28 (11), 1218-1224. e4, 2020 | 203 | 2020 |
| Deep learning based drug screening for novel coronavirus 2019-nCov H Zhang, KM Saravanan, Y Yang, MT Hossain, J Li, X Ren, Y Pan, Y Wei Interdisciplinary Sciences: Computational Life Sciences 12, 368-376, 2020 | 190 | 2020 |
| Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets Y Yang, F Ye, N Zhu, W Wang, Y Deng, Z Zhao, W Tan Scientific reports 5 (1), 17554, 2015 | 164 | 2015 |
| Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China F Zhang, Y Bi, J Wang, G Wong, W Shi, F Hu, Y Yang, L Yang, X Deng, ... Journal of Infection 75 (1), 71-75, 2017 | 154 | 2017 |
| Dominant subtype switch in avian influenza viruses during 2016–2019 in China Y Bi, J Li, S Li, G Fu, T Jin, C Zhang, Y Yang, Z Ma, W Tian, J Li, S Xiao, ... Nature Communications 11 (1), 5909, 2020 | 138 | 2020 |
| Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in cultured Vero cells M Yang, J Wei, T Huang, L Lei, C Shen, J Lai, M Yang, L Liu, Y Yang, ... Phytotherapy Research 35 (3), 1127, 2020 | 118 | 2020 |
| New threats from H7N9 influenza virus: spread and evolution of high-and low-pathogenicity variants with high genomic diversity in wave five C Quan, W Shi, Y Yang, Y Yang, X Liu, W Xu, H Li, J Li, Q Wang, Z Tong, ... Journal of virology 92 (11), 10.1128/jvi. 00301-18, 2018 | 111 | 2018 |
| Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection Y Yang, M Yang, Y Peng, Y Liang, J Wei, L Xing, L Guo, X Li, J Li, J Wang, ... Nature microbiology 7 (3), 423-433, 2022 | 110 | 2022 |
| Mpox (formerly monkeypox): pathogenesis, prevention, and treatment J Lu, H Xing, C Wang, M Tang, C Wu, F Ye, L Yin, Y Yang, W Tan, L Shen Signal Transduction and Targeted Therapy 8 (1), 458, 2023 | 68 | 2023 |
| A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro H Zhang, Y Yang, J Li, M Wang, KM Saravanan, J Wei, J Tze-Yang Ng, ... PLoS computational biology 16 (12), e1008489, 2020 | 62 | 2020 |
